PD-L1 POSITIVE

Clinical trials for PD-L1 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new PD-L1 POSITIVE trials appear

Sign up with your email to follow new studies for PD-L1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 2

New drug combo aims to keep rare skin cancer from returning

Disease control Recruiting now

This study is for people with a rare type of skin cancer called mucosal melanoma that has been completely removed by surgery and tests positive for PD-L1. The trial compares the effects of adding the immunotherapy drug sintilimab to standard chemotherapy versus chemotherapy alone…

Matched conditions: PD-L1 POSITIVE

Phase: PHASE2 • Sponsor: The First Hospital of Jilin University • Aim: Disease control

Last updated May 06, 2026 16:15 UTC

PD-L1 POSITIVE

Get alerted when new PD-L1 POSITIVE trials appear

New drug combo aims to keep rare skin cancer from returning